Product Information
Name:
Trelagliptin
Synonyms:
- (R)-2-[[6-(3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl]methyl]-4-fluorobenzonitrile
- 2-[[6-[(3R)-3-Amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluorobenzonitrile
- (R)-2-[[6-(3-AMinopiperidin-1-yl)-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl]Methyl]-4-fluorobenzonitrile
- Benzonitrile, 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluoro-
Description:
Trelagliptin is a potent, selective and orally active agonist of the glucagon-like peptide-1 receptor (GLP-1R) that improves glucose homeostasis in patients with type 2 diabetes. Trelagliptin has been shown to increase insulin secretion and reduce postprandial hyperglycemia. The drug binds to GLP-1Rs on the surface of beta cells in the pancreas. This binding stimulates cAMP production, leading to increased insulin release from pancreatic beta cells. Trelagliptin is chemically stable in human serum, exhibiting no significant changes after incubation for up to 72 hours at 37°C.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
357.38 g/mol
Formula:
C18H20FN5O2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
